Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1404-1404
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Immune Checkpoint Inhibitor Therapy in Oncology
Sean Tan, Daphne Day, Stephen J. Nicholls, et al.
JACC CardioOncology (2022) Vol. 4, Iss. 5, pp. 579-597
Open Access | Times Cited: 93
Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 128, pp. 108702-108702
Closed Access | Times Cited: 18
CT texture analysis and node-RADS CT score of mediastinal lymph nodes - diagnostic performance in lung cancer patients
Hans‐Jonas Meyer, Benedikt Schnarkowski, Johanna Pappisch, et al.
Cancer Imaging (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis
Yu‐Tzu Chang, Wan-Ying Lin, Yu-Cheng Chang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 284-284
Open Access | Times Cited: 23
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
Jing Miao, Sandra M. Herrmann
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1834-1844
Open Access | Times Cited: 14
Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model
Jing Gong, Ting Wang, Zezhou Wang, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma
Di Wu, Yibing Liu, Jianjun Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer
Ruoyu Lu, Ziqi Wang, Wentao Tian, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021)
Shanshan Yang, Suya Zhao, Yixiang Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors
Tingwei Wang, Heng‐Sheng Chao, Hwa‐Yen Chiu, et al.
Translational Oncology (2023) Vol. 39, pp. 101826-101826
Open Access | Times Cited: 11
Dysregulation of peripheral and intratumoral KLRG1+ CD8+ T cells is associated with immune evasion in patients with non-small-cell lung cancer
Juan Zeng, Lu Zhang, Shiqi Ma, et al.
Translational Oncology (2024) Vol. 45, pp. 101968-101968
Open Access | Times Cited: 4
Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review
Honglin Li, Lei Zhang, Feiran Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
A narrative review on perioperative systemic therapy in non-small cell lung cancer
Robert Hsu, Zhaohui Arter, Darin Poei, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 931-954
Open Access | Times Cited: 3
Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review
Na Li, Zixuan Wan, Dongyan Lu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Anti-PD-(L)1 therapy of non-small cell lung cancer–A summary of clinical trials and current progresses
Keywan Mortezaee, Jamal Majidpoor
Heliyon (2023) Vol. 9, Iss. 3, pp. e14566-e14566
Open Access | Times Cited: 7
Single-cell RNA sequencing reveals distinct transcriptomic profiles and evolutionary patterns in lung cancer brain metastasis
Xiaoyuan Wang, Hao Liang, Xiaoli Tang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27071-e27071
Open Access | Times Cited: 2
Role of Postoperative Radiotherapy on High-Risk Stage pIIIA-N2 Non-Small Cell Lung Cancer Patients After Complete Resection and Adjuvant Chemotherapy: A Retrospective Cohort Study
Zu Yi Chen, Huan Wei Liang, Yang Liu, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 2, pp. 309-318
Open Access | Times Cited: 2
Identification of cellular senescence-associated genes as new biomarkers for predicting the prognosis and immunotherapy response of non-small cell lung cancer and construction of a prognostic model
Dandan Xu, Xiaohong Chen, Mingyuan Wu, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28278-e28278
Open Access | Times Cited: 2
Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer
Hao Jiang, Borui Li, Min Wu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma
Junzhi Liu, Huimin Li, Nannan Zhang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 25, pp. 4034-4055
Closed Access | Times Cited: 2
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
Shike Lou, Xiaoyin Wang, Fei Yuan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis
Tzu‐Rong Peng, Pei‐Fei Liao, Ta‐Wei Wu
Thoracic Cancer (2023) Vol. 14, Iss. 10, pp. 929-939
Open Access | Times Cited: 6
Total alkaloids in Stephania tetrandra induce apoptosis by regulating BBC3 in human non–small cell lung cancer cells
Bichen Li, Juan Chen, Jia He, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114635-114635
Open Access | Times Cited: 6
Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis
Ruiyi Deng, Hua Zhang, Yuan Li, et al.
Journal of Immunotherapy (2022) Vol. 46, Iss. 2, pp. 43-55
Closed Access | Times Cited: 9
Fatal limbic encephalitis as paraneoplastic neurological syndrome in a patient with lung adenocarcinoma positive for antiamphiphysin antibody after durvalumab treatment
Yuto IWANAGA, Takako Kawaguchi, Kei Yamasaki, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 19, pp. 1899-1903
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top